Courses

Nutrition, Diabetes, and Obesity Care: Bridging Evidence and Clinical Practice

How can evidence-based nutrition strategies optimize care and improve outcomes for patients with diabetes and obesity?

Presenters: Robert Kushner, MD; Ana Maria Gomez, MD; Carla Prado, PhD, RD

Program Date: 22 June 2025

Publication Date: 08 January 2026

Continuing Education Credits: Nurse Contact 1.0 CE; Dietitian 1.0 CPEU

Course Description

This course provides an evidence‑based overview of how nutrition influences the prevention and management of diabetes, obesity, and cardiometabolic risk, emphasizing strategies grounded in current research. Participants will examine the clinical benefits of diabetes‑specific formulas and the role of targeted nutrition in supporting muscle health, including for those using incretin‑mimetic therapies. Originally presented live at the American Diabetes Association Scientific Sessions on 22 June 2025.

Course Objectives:
  • Explore the latest evidence on the role of nutrition in managing diabetes, obesity, and cardiometabolic risk.
  • Examine evidence supporting the role of diabetes-specific formulas in addressing the nutritional and health needs of people with diabetes and obesity.
  • Describe the role of nutrition in supporting muscle health in patients with diabetes, obesity, and cardiometabolic risk using incretin-mimetic therapies.
  • Discuss opportunities for future research and innovation in nutrition support and the use of diabetes-specific formula.
Key Takeaways:
  • Diabetes-specific formulas can improve glycemic control, body composition, and cardiometabolic risk factors in people with type 2 diabetes. When combined with a low-calorie diet, these formulas can enhance weight loss, quality of life, and increase the likelihood of diabetes remission.
  • Weight loss is a key component of diabetes and obesity care. Sustained weight loss improves glycemic control and reduces cardiometabolic risk. Even modest reductions of 5–10% deliver significant clinical benefits, while greater weight loss (≥15%) can potentially lead to remission of type 2 diabetes.
  • Muscle preservation during weight loss and incretin-mimetic therapy is important for long-term health and metabolic resilience. Higher protein intake is key, but often challenging, so diabetes-specific formulas offer a practical solution to help maintain lean mass and support better outcomes.

Performance Indicators: 9.1.5, 9.2.2, 11.3.4

Activity Code: 190679

Related Questions:
  • What is the relationship between obesity and type 2 diabetes?
    Obesity and diabetes often coexist; 60–90% of people with type 2 diabetes also have obesity. This clustering is referred to as a “syndemic” or “diabesity,” driven by abnormal adiposity, insulin resistance, and metabolic dysfunction.
  • Why might diabetes-specific formulas be more effective than standard diets?
    A diabetes-specific formula includes slowly digestible carbohydrates with a low glycemic index, soluble fiber, healthy fat, particularly monounsaturated fatty acids, high-quality protein, and specific micronutrients. Studies show that DSF combined with calorie restriction is more effective than conventional diets for weight loss and glycemic control, and it may increase the chances of diabetes remission.
  • How do incretin-mimetic therapies impact muscle health during weight loss?
    These therapies are highly effective for weight reduction but can lead to substantial loss of fat-free mass, including muscle mass. Preserving muscle is critical for metabolic resilience and long-term health, which is why higher protein intake and diabetes-specific formulas are practical strategies to help maintain lean mass.

Course Instructor Bio(s)

Robert Kushner, MD, MS

Professor of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, IL, USA

Robert Kushner, MD, MS, is Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, and former Director of the Center for Lifestyle Medicine in Chicago, IL. After completing a residency in Internal Medicine at Northwestern University, he went on to complete a postgraduate fellowship in Clinical Nutrition and earned a master’s degree in Clinical Nutrition and Nutritional Biology from the University of Chicago, IL. Dr Kushner is past President of The Obesity Society, the American Society for Parenteral and Enteral Nutrition, and the American Board of Physician Nutrition Specialists, and a founder and first Chair of the American Board of Obesity Medicine (ABOM).

Dr Kushner has authored over 250 original articles, reviews, books, and book chapters covering nutrition, obesity, and medical education, and is an internationally recognized expert on the care of patients with overweight or obesity. He is the author/editor of multiple books; current books include Nutrition and Bariatric Surgery (CRC Press, 2015), Lifestyle Medicine: A Manual for Clinical Practice (Springer, 2016), Creating a Lifestyle Medicine Center (Springer, 2020), and Six Factors to Fit – Weight Loss that Works for You! (Eat Right Press, 2020), and Primary Care: Evaluation and Management of Obesity (Wolters Kluwer, 2022). His two newest books, Lifestyle Medicine - Closing Research, Practice, and Knowledge Gaps (Springer) and Patient-Centered Weight Management (Eat Right Press), are due out this Spring.

Ana Maria Gomez, MD

Head of Endocrinology, Hospital Universitario San Ignacio
Professor of Medicine, Javeriana University
Bogotá, Columbia

Dr Ana María Gómez is an Internist and Endocrinologist and a professor at Pontificia Universidad Javeriana in Bogotá, Colombia. She is the Head of the Endocrinology Unit at Hospital Universitario San Ignacio and the Coordinator of the Endocrinology Postgraduate Program at Pontificia Universidad Javeriana. She is recognized as a Senior Researcher by the Ministry of Science, Technology, and Innovation of Colombia, the entity responsible for promoting and strengthening scientific, technological, and innovation development in the country.

Carla Prado, PhD, RD, FCAHS

Distinguished University Professor
Research Chair, Integrative Nutrition, Body Composition & Energy Metabolism
Director, Human Nutrition Research Unit
University of Alberta
Edmonton, AB, CA

Dr Carla Prado is a Distinguished University Professor and a Canada Research Chair in Integrative Nutrition, Body Composition, and Energy Metabolism (Tier 1). She is also a registered dietitian. She directs the Human Nutrition Research Unit, recognized as one of the world’s leading research and training facilities for body composition and energy metabolism assessments.

Dr Prado's research focuses on assessing nutritional status through precise measurements of body composition and energy metabolism. Her current research program investigates the prevalence and health outcomes of abnormal body composition phenotypes in patients with diverse chronic conditions. She is also developing targeted nutrition interventions to optimize body composition and improve health outcomes.

Dr Prado is an Associate Editor for two of the top journals in her field, serves on several international clinical guideline committees, and is a Fellow of the Canadian Academy of Health Sciences as well as a member of the Royal Society of Canada’s College of New Scholars, Artists, and Scientists. She was named one of Canada’s Top 40 Under 40, one of Canada’s Most Powerful Women: Top 100, and a Highly Cited Researcher by Clarivate™ (Web of Science), a recognition placing her among the top 1% of researchers globally for her significant and broad influence in the field.

 

Category
Highlighted References:
  • American Diabetes Association Professional Practice Committee. Diabetes Care. 2025;48(1 Suppl 1):S167-S180.
  • American Diabetes Association Professional Practice Committee. Diabetes Care. 2025;48(Supplement_1):S86-S127. 
  • Mechanick JI, et al. Obes Rev. 2025;26(1):e13841.
  • Lin S, et al. Consensus Statement: The Use of Diabetes Specific Nutritional Formulas in Type 2 Diabetes. Published August 2024.
  • Mechanick JI, et al. J Am Coll Cardiol. 2020;75(5):525-538.
  • Prado CM, et al. Nat Rev Endocrinol. 2024;20(5): 261–277. 
  • Magkos F, et al. Cell Metab. 2016;23(4):591-601.
  • Knowler WC, et al. N Engl J Med. 2002;346(6):393-403. 
  • Look AHEAD Research Group, et al. Diabetes Care. 2007;30(6):1374-1383.
  • Look AHEAD Research Group. N Engl J Med. 2013;369(2):145-154. 
  • Lean ME, et al. Lancet. 2018;391(10120):541-551.
  • Jenkins DJA, et al. Lancet Diabetes Endocrinol. 2024;12(2):107-118.
  • Chiavaroli L, et al. BMJ 2021;374:n1651.

Abbott Nutrition’s Provider Statement for Nursing CEs:

Abbott Nutrition Health Institute is an approved provider of continuing nursing education by the California Board of Registered Nursing Provider #CEP 11213.

Abbott Nutrition’s Statement for Dietitian CPEUs:

This educational activity has been prior-approved by the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive the specified continuing professional education units (CPEUs) for completion of this program/material.